CytoMed Therapeutics Limited Ordinary Shares (NASDAQ: GDTC) last traded at $1.03, up 14.57% on the session. The quote above updates while this page is open; the figures below are drawn from CytoMed Therapeutics Limited Ordinary Shares’s own filings and are restated only when a new one is published.
CytoMed Therapeutics Limited Ordinary Shares (GDTC) company overview
CytoMed Therapeutics Limited Ordinary Shares trades on NASDAQ under the ticker GDTC. Its market capitalisation is $12.18 million.
GDTC valuation
Valuation measures for CytoMed Therapeutics Limited Ordinary Shares, derived from the latest quote and its most recent SEC filing.
Market cap
$12.18M
Beta
0.08
GDTC financials
Trailing-twelve-month figures tagged in CytoMed Therapeutics Limited Ordinary Shares's XBRL filings with the SEC.
CytoMed Therapeutics Limited Ordinary Shares (GDTC) last traded at $1.03, up 14.57% on the session. FurlPay quotes GDTC from Yahoo Finance and stamps each figure with the exchange time it printed.
What exchange is GDTC listed on?
CytoMed Therapeutics Limited Ordinary Shares is listed on NASDAQ under the ticker symbol GDTC.
What is CytoMed Therapeutics Limited Ordinary Shares's market cap?
CytoMed Therapeutics Limited Ordinary Shares has a market capitalisation of $12.18 million, derived from its shares outstanding as reported in its SEC filings and the latest quoted price.
What is GDTC's 52-week range?
Over the past 52 weeks GDTC has traded between $0.68 and $3.68.
Data sources
Price, range and volume — Yahoo Finance. Quotes may be delayed; each carries the exchange timestamp it printed with.
Financials and valuation — the company’s own XBRL filings with the U.S. Securities and Exchange Commission (CIK 0001873093), period ending 2025-12-31.
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.